DMC Reaches BPR Milestone with Submission of Biocidal Product Dossiers
Horgen, Switzerland - June 22, 2017 - Today, Dow Microbial Control, a business unit of The Dow Chemical Company (NYSE: DOW), submitted the dossiers for the authorization of biocidal products containing CMIT/MIT1 as the single active ingredient to the European Chemicals Agency under the Biocidal Products Regulation (BPR). The investment and support by Dow enables the industry to continue to use CMIT/MIT in Europe across the multiple applications supported in Dow’s BPR Biocidal Product dossiers. This submission initiates the extension of national approvals for three years beyond the July 1st, 2017 expiration date for products included in the dossier.
Our regulatory team’s experience in submitting product dossiers and our in-depth knowledge of CMIT/MIT brought us a step further in our BPR product registration support strategy for 19 active substances and multiple products Dow supports in the EU under the BPR.
Dow’s long-term support for CMIT/MIT continues
Dow invented CMIT/MIT and first brought it to the European market with KATHON™ Biocides in 1976. The submitted dossiers for solid, solvent- and aqueous-based products are based on extensive efficacy data and comprehensive risk assessments that determined the products offer the desired antimicrobial efficacy and are safe to use. The product family covers concentrations ranging from 1.5-14 percent, giving our customers the formulation flexibility they need.
CMIT/MIT (CAS 55965-84-9) is supported by Dow Microbial Control in the EU, and has been approved2 as an active ingredient under the BPR for product types:
- Product Type 2: Disinfectants and algaecides not intended for direct application to humans or animals
- Product Type 4: Food and feed area
- Product Type 6: Preservatives for products during storage
- Product Type 11: Preservatives for liquid-cooling and processing systems
- Product Type 12: Slimicides
- Product Type 13: Working or cutting fluid preservatives
Submitted biocidal products containing CMIT/MIT as the single active ingredient:
- KATHON™ CF 1400 Biocide
- KATHON™ CF 400 Biocide
- KATHON™ CF 210 Biocide
- KATHON™ CF 150 Biocide
- KATHON™ CG ICP Biocide
- KATHON™ CG/ICP II Biocide
- KATHON™ LX 1400 Biocide
- KATHON™ LX 300 Biocide
- KATHON™ LX 150 Biocide
- KATHON™ LX Biocide
- KATHON™ LXE Biocide
- KATHON™ MK Biocide
- KATHON™ 886 F Biocide
- KATHON™ WT Biocide
- KATHON™ WT 300 Biocide
- KATHON™ WT 210 Biocide
- KATHON™ WTE Biocide
- KATHON™ 886 MW Biocide
- KATHON™ MWE Biocide
- KATHON™ FP 1.5 Biocide
- KATHON™ HP 120 Biocide
- KATHON™ 7G Antimicrobial
Following the EU Standing Committee on Biocidal Products’ approval of CMIT/MIT (CAS 55965-84-9) as an active substance in 2016, we are excited to see an active that we have supported as a review program participant since 2007 move into the next phase.
About Dow Microbial Control
Dow Microbial Control innovates with science and technology to provide long-term viable and sustainable microbial control. Our comprehensive global offering provides customers with solutions to optimize formulations, including a high performing and technically supported selection of registered actives and products. With world-class people organization-wide and a broad portfolio of microbial control technologies, Dow Microbial Control can help solve most any microbial control problem. From specialty and highly regulated to non-regulated, the company has the experience and the essentials for more sustainable microbial control protection for products and processes. Visit www.DowMicrobialControl.com.
Dow combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from material, polymer, chemical and biological science to help address many of the world's most challenging problems, such as the need for fresh food, safer and more sustainable transportation, clean water, energy efficiency, more durable infrastructure, and increasing agricultural productivity. Dow's integrated, market-driven portfolio delivers a broad range of technology-based products and solutions to customers in 175 countries and in high-growth sectors such as packaging, infrastructure, transportation, consumer care, electronics, and agriculture. In 2016, Dow had annual sales of $48 billion and employed approximately 56,000 people worldwide. The Company's more than 7,000 product families are manufactured at 189 sites in 34 countries across the globe. References to \"Dow\" or the \"Company\" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.
For more information, please contact us.
1 Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6) (Mixture of CMIT/MIT) CAS: 55965-84-9
2 Commission Implementing Regulation (EU) 2016/131 of 1 February 2016 approving C(M)IT/MIT (3:1) as an existing active substance for use in biocidal products for product-types 2, 4, 6, 11, 12 and 13